Review Article

Bidirectional Association between Hypertension and NAFLD: A Systematic Review and Meta-Analysis of Observational Studies

Table 1

Characteristics of 11 observational studies included in the meta-analysis.

Author and yearCountryStudy characteristicsMean follow-up durationFatty liver diagnosisHypertension diagnosisOutcomesAdjustmentsQuality score

Ryoo et al., 2014 [12]South KoreaPopulation-based; n = 22,090 men; mean age 42.1 y; 6,554 mild NAFLD; 1,007 moderate to severe NAFLD; without baseline HTN; 3,820 incident HTNProspective cohort; 5 yearsLiver ultrasoundSBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or current use of antihypertensive agentsAssociation with incident HTNAge, BMI, TG, serum creatinine, AST, ALT, GGT, recent smoking status, regular exercise, diabetes mellitus7
Sung et al., 2014 [13]South KoreaPopulation-based; n = 11,448; mean age 41 y; 7,940 men; 2,958 baseline fatty liver; without baseline HTN; 911 incident HTNRetrospective cohort; 5 yearsLiver ultrasoundSBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or current use of antihypertensive agentsAssociation with incident HTNAge, sex, alcohol consumption, smoking status, exercise, SBP, BMI, diabetes status, GGT, HOMA-IR, eGFR, change in BMI between baseline and follow-up8
Huh et al., 2015 [14]South KoreaPopulation-based; n = 1,521; age 40–70 y; 484 men; 124 baseline NAFLD; without baseline HTN; 153 incident HTNProspective cohort; 2.6 yearsFLI ≥ 60SBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or current use of antihypertensive agentsAssociation with incident HTNAge, gender, baseline SBP, baseline DBP, smoking, regular exercise, alcohol intake, diabetes, log ALT, log HOMA-IR, hsCRP, serum creatinine, adiponectin7
Ma et al., 2016 [8]USAPopulation-based; n = 1,051; mean age 45 y; 572 men; 187 baseline fatty liver; 82 baseline HTNProspective cohort; 6 yearsCTSBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or current use of antihypertensive agentsAssociation with incident HTNAge, sex, baseline current smoking, physical activity, alcohol intake, SBP, DBP, VAT, delta VAT, delta LPR7
Association with incident fatty liver
Kim et al., 2017 [15]South KoreaPopulation-based; n = 6,331; mean age 51y; 2,995 men; 1,517 baseline NAFLD; without baseline HTN; 891 incident HTNRetrospective study; 8.7 yearsFLI, hepatic steatosis index, and comprehensive NAFLD score; two or three indexes were satisfiedBlood pressure levelsAssociation with incident HTNAge, gender, diabetes mellitus, family history of HTN and obesity7
Liu et al., 2018 [9]ChinaPopulation-based; 6,704 HTN-free subjects; 2,008 baseline NAFLD; 2,561 incident HTN; 9,328 NAFLD-free subjects; 4,436 baseline HTN; 2,289 incident NAFLDProspective cohort; 5 yearsLiver ultrasoundSBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or current use of antihypertensive agents or prior diagnosisAssociation with incident HTNAge, sex, past history of CHD, family history of HTN, diabetes, BMI9
Association with incident NAFLD
Zhou and Cen, 2018 [16]ChinaPopulation-based; n = 4,687; mean age 40 y; 3,177 men; 304 baseline NAFLD (FLI ≥ 60); without baseline HTN; 2,047 incident HTNProspective cohort; 9 yearsFLISBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or current use of antihypertensive agentsAssociation with incident HTNAge, gender, indicators of metabolic syndrome (waist circumference, SBP, DBP, FPG, HDL-C, TG)8
Bonnet et al., 2017 [17]FrancePopulation-based; n = 2,565 (insulin resistance cohort); aged 30–65y; 1,138 men; 220 baseline NAFLD (FLI ≥60); without baseline HTN; 1,021 incident HTNProspective cohort; 9 yearsFLISBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or current use of antihypertensive agentsAssociation with incident HTNAge, sex, smoking, FPG, alcohol intake7
Lau et al., 2010 [18]GermanyPopulation-based; n = 3,191; 1,532 men; aged 20–79 yearsProspective cohort; 5.3 yearsLiver ultrasound and ASTSBP ≥ 140 mmHg and/or DBP ≥ 90 mmHg or current use of antihypertensive agentsAssociation with incident HTNAge, sex, waist circumference, BMI, diabetes mellitus, alcohol consumption, use of antihypertensive medication8
Tsuneto et al., 2010 [10]Japan1,635 Nagasaki atomic bomb survivors; 606 men; without baseline fatty liver; 323 incident fatty liverRetrospective cohort; 11.6 yearsLiver ultrasoundSBP ≥ 130 mmHg and/or DBP ≥ 85 mmHgAssociation with incident fatty liverAge, sex, smoking and drinking habits, obesity, hypercholesterolemia, low HDL-C, hypertriglyceridemia, glucose intolerance, atomic radiation dose7
Zhang et al., 2015 [11]ChinaPopulation-based; n = 15,791; mean age 42.5 y; 7,922 men; 877 baseline HTN; without baseline NAFLD;
3,913 incident NAFLD
Prospective cohort; 3.3 yearsLiver ultrasoundSBP ≥ 140 mmHg and/or DBP values ≥ 90 mmHg or prior diagnosisAssociation with incident NAFLDAge, gender, smoking status, diet, regular exercise7

Abbreviations: HTN, hypertension; SBP, systolic blood pressure; DBP, diastolic blood pressure; NAFLD, non-alcoholic fatty liver disease; BMI, body mass index; FLI, fatty liver index; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, glutamyl transpeptidase; HDL-C, high-density lipoprotein cholesterol; hsCRP, high-sensitivity C-reactive protein; TG, triglyceride; FPG, fasting plasma glucose; HOMA-IR, homeostasis model assessment of insulin resistance; VAT, visceral adipose tissue; LPR, liver-phantom ratio; and CHD, coronary heart disease. The Newcastle–Ottawa Scale (NOS) was applied for the quality evaluation of cohort studies. The quality of each cohort study ranges from 1 to 9 points based on three domains: the cohort selection (maximum 4 points), the comparability of the cohort design and analysis (maximum 2 points), and the adequacy of the outcome measures (maximum 3 points). Studies achieving a score of at least seven points were considered high quality.